4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-23-037611
Chief Operating Officer sold 18,340 shares at an average $16.11 ($295,405)
- Chief Operating Officer acquired 18,340 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bensen Daniel Chief Operating Officer | 2023-06-13 | Option exercise 10b5-1 | +5,628 | $0.61 | $3,433 | 533,609 | D |
| Bensen Daniel Chief Operating Officer | 2023-06-13 | Sale 10b5-1 | −5,628 | $16.01 | $90,129 | 527,981 | D |
| Bensen Daniel Chief Operating Officer | 2023-06-14 | Option exercise 10b5-1 | +120 | $0.61 | $73 | 528,101 | D |
| Bensen Daniel Chief Operating Officer | 2023-06-14 | Sale 10b5-1 | −120 | $16.45 | $1,974 | 527,981 | D |
| Bensen Daniel Chief Operating Officer | 2023-06-15 | Option exercise 10b5-1 | +12,592 | $0.61 | $7,681 | 540,573 | D |
| Bensen Daniel Chief Operating Officer | 2023-06-15 | Sale 10b5-1 | −12,592 | $16.15 | $203,302 | 527,981 | D |
| Derivatives | |||||||
| Bensen Daniel Chief Operating Officer | 2023-06-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,628 | 241,774 | D | ||
| Bensen Daniel Chief Operating Officer | 2023-06-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −120 | 241,654 | D | ||
| Bensen Daniel Chief Operating Officer | 2023-06-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,592 | 229,062 | D | ||
| Open-market sales · 18,340 sh · avg $16.11 · $295,405 | |||||||
Loading xslF345X04/doc4.xml…